The Tyrosine Kinase Lck Is Involved in Regulation of Mitochondrial Apoptosis Pathways

Total Page:16

File Type:pdf, Size:1020Kb

The Tyrosine Kinase Lck Is Involved in Regulation of Mitochondrial Apoptosis Pathways Oncogene (2003) 22, 176–185 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways Claus Belka*,1,3, Charlotte Gruber1,3, Verena Jendrossek1, Sebastian Wesselborg2 and Wilfried Budach1 1Department of Radiation Oncology, University of Tu¨bingen, Hoppe Seyler Str. 3, D-72076 Tu¨bingen, Germany; 2Department of Internal Medicine I, University of Tu¨bingen, Otfried Mu¨ller Str. 10, D-72076 Tu¨bingen, Germany The induction of apoptosis requires the activation of a of the caspase cascade at the receptor level, DNA highly coordinated signaling network ultimately leading to damage and stress-mediated caspase activation and the activation of caspases. In previous experiments we and apoptosis are triggered mainly by mitochondrial alter- others have shown that the tyrosine kinase Lck is required ations (Belka et al., 2000b, 2001; Newton and Strasser, for adequate apoptosis induction in response to ionizing 2000). radiation, ceramide incubation and overexpression of the Mitochondrial apoptosis is basically regulated by a HIV-TAT protein. However, the position of Lck within complex interplay of pro- and antiapoptotic Bcl-2-like given apoptotic signaling cascades remains unclear. We proteins. DNA damage or cellular stress triggers the therefore aimed to define the role of Lck during radiation- transcriptional activation of the proapoptotic Bax-like induced apoptosis. Apoptosis induction in response to molecules Bax, Bak and the BH3-only proteins Noxa and ionizing radiation, CD95 or TRAIL receptor stimulation Puma. Although the interplay of Bax-like molecules and was determined in Jurkat T-cells, the Lck-deficient BH3-only proteins is not completely understood, it has Jurkat clone JCaM1.6- and Lck-retransfected been shown that an interaction of molecules belonging to JCaM1.6/Lck. No apoptosis, release of cytochrome c, either group is crucial for the subsequent release of breakdown of the mitochondrial potential were detectable cytochrome c (Cheng et al., 2001). The release of during the first 48 h after irradiation of JCaM1.6 cells. In cytochrome c together with dATP and APAF-1 in turn parallel, no activation of caspase-9, -8 and -3 was triggers the autoproteolytic activation of caspases (re- detectable. Since mitochondrial apoptosis pathways act viewed in: Belka and Budach, 2002; Rudner et al., 2002). within a feedback mechanism during death-receptor- In this regard, the role of certain caspases was also mediated apoptosis, the influence of the Lck defect on found to be different. While caspase-8, which is directly CD95/Fas/Apo-1-L or TRAIL-induced apoptosis was activated at the receptor complex, was shown to be the also tested. Both stimuli induced apoptosis in Lck- key caspase for death-receptor-mediated apoptosis deficient cells. However, the kinetics of apoptosis induc- (Varfolomeev et al., 1998), caspase-9 is crucial for tion determined by caspase-8, -9 and -3 activation as well DNA-damage-related apoptosis and is activated follow- as DWm breakdown was slowed. We conclude that the Lck ing cytochrome c release from the mitochondrial deficiency influences early steps during radiation-induced intermembrane space (Hakem et al., 1998; Kuida et al., mitochondrial alterations. 1998; Soengas et al., 1999). In this context, we have shown that the apoptotic process triggered by ionizing Oncogene (2003) 22, 176–185. doi:10.1038/sj.onc.1206103 radiation is delayed, but not abrogated in cells lacking caspase-8 (Belka et al., 2000b). Thus, two distinct pathways are responsible for the induction of apoptosis Introduction in response to death receptor ligation or DNA damage or stress (Belka et al., 2000b; Engels et al., 2000; The apoptotic process is regulated by a wide array of Dunkern et al., 2001; Stepczynska et al., 2001; Tomicic diverse molecules. Depending on the stimulus applied et al., 2002; Wieder et al., 2001). two apoptotic cascades can be distinguished: whereas In addition to the essential role of caspases, it was death receptor stimulation acts via a direct activation shown that the tyrosine kinase Lck is involved in the regulation of apoptosis induced by ionizing radiation (Belka et al., 1999), the HIV-TAT protein (Manna and *Correspondence: C Belka, Department of Radiation Oncology, Aggarwal, 2000)and ceramide (Manna et al., 2000). In University of Tu¨ bingen, Hoppe Seyler Str. 3, Tu¨ bingen D-72076, this regard, it is important that the release of ceramides Germany; from cellular membranes is considered to be a key step E-mail: [email protected], http:www.radiation-research.de during radiation-induced apoptosis in some (Santana 3These two authors share first authorship Received 8 July 2002; revised 30 September 2002; accepted 4 et al., 1996; Pena et al., 2000)but not all cell models October 2002 (Burek et al., 2001). Lck and mitochondrial apaptosis pathways C Belka et al 177 Lck belongs to the src-like tyrosine kinase family and apoptotic signaling. To this end, we analyzed the key is normally required for the adequate propagation of T- steps in apoptosis signaling cascade in Lck-deficient cell receptor signals. After stimulation of the T-cell JCaM1.6 and Lck expressing JCaM1.6 cells upon death receptor complex by the respective antigen in combina- receptor ligation and irradiation. tion with an MHC molecule, Lck becomes activated and is involved in the phosphorylation of critical residues of the TCR complex. These phophorylations are essential Results for downstream signaling events including calcium influx, activation of the transcription factor NFAT Apoptosis induction, Lck function and expression and the mitogenic kinases Erk1 and Erk2 (Straus and Weiss, 1992; Kabouridis et al., 1997; Samelson, 2002). In a first set of experiments apoptosis induction after Using normal Jurkat Tcells, the Lck-deficient Jurkat irradiation of JCaM1.6 and JCaM1.6/Lck cells with subclone JCaM1.6 and Lck-transfected JCaM1.6/Lck 10 Gy was followed over 72 h. As shown in Figure 1a, cells, we could show previously that Lck is also the onset of apoptosis was abrogated in cells lacking Lck important for the regulation of apoptosis in response with no apoptosis being detectable prior to 72 h to ionizing radiation (Belka et al., 1999). JCaM1.6 and (23.9711% in Lck-negative cells vs 71.7712.4%). At JCaM1.6/Lck were initially employed to prove that Lck 96 h apoptotic changes also increased in Lck-deficient is involved in T-cell receptor signal transduction (Straus cells (41.2722.5%). However, a strong difference and Weiss, 1992). This finding is paralleled by similar between the Lck-deficient and the Lck-re-expressing results from B-cells, where the B-cell receptor associated cells (75.3711.6%)remained detectable. src-like kinase BTK is essential for radiation-induced In parallel experiments, the expression levels of Lck apoptosis (Uckun et al., 1996). In this context, the and the function of Lck-mediated signaling pathways kinase domain of BTK was crucial for the apoptotic were tested in Jurkat, JCaM1.6 and JCaM1.6/Lck. response to ionizing radiation. In addition to the Using an antibody against the C-terminus of Lck, the findings on BTK, it was shown that activation of Lck expression of Lck was absent in JCaM1.6 cells, while by CD19 crosslinking promoted radiation-induced comparable levels of Lck were detectable in Jurkat and apoptosis in a radiation-resistant B-lymphoma line JCaM1.6/Lck cells (Figure 1b). The functional integrity (Waddick et al., 1993). Similarly, the src-like kinase of Lck-mediated signaling pathways in the JCaM1.6/ Lyn was suggested to be involved in apoptosis regula- Lck cells was verified by analyzing the capability of the tion in response to UV light in DT40 B-cells (Qin et al., respective cell line to respond to CD3/T-cell receptor 1997). (TCR)stimulation with an activation of Erk1/2 kinases. Since Lck has been shown to be involved in apoptosis The CD3/TCR complex was stimulated using phytohe- induction in response to ceramide, radiation and HIV- magglutinin-L (PHA-L, 50 mg/ml)and activation of TAT protein, we aimed to further define its role for Erk1/2 was detected using activation specific antibodies Figure 1 Radiation-induced apoptosis in Lck-deficient cells. JCaM1.6 are negative for Lck expression and function and do not undergo apoptosis in response to ionizing radiation, whereas Jurkat control cells and retransfected JCaM1.6/Lck cells express functional Lck and are sensitive to irradiation. (a)Jurkat cells, Lck negative JCaM1.6 and retransfected JCaM1.6/Lck cells were exposed to 10 Gy ionizing radiation and apoptosis induction was determined every 12 up to 72 h by flow cytometry. (b)Expression of Lck was verfied by Western blotting using an antibody against the C-terminus of Lck. (c)Downstream signaling of Lck was determined by Erk1/2 activation in response to phytohaemagglutinin stimulation. Data show means7s.d. (n ¼ 3) (a) or one representative of three independent experiments (b + c). Oncogene Lck and mitochondrial apaptosis pathways C Belka et al 178 directed against the active kinase (Figure 1c). After determined. As shown in Figure 2, cleavage of PARP by stimulation of normal Jurkat cells with PHA-L, Erk1/2 caspase-3 was not detectable in JCaM1.6 cells, whereas kinase was rapidly activated as indicated by the it clearly occurred in the Lck-expressing JCaM1.6 cells. detection of phosphorylated Erk1/2. No such activation Although caspase-8 is an activator caspase for was detectable in JCaM1.6 cells, whereas treatment of receptor-mediated apoptosis, recent work indicated that JCaM1.6/Lck cell with PHA-L clearly induced Erk1/2 it acts as executor caspase during radiation or drug- phosphorylation. Taken together, the data prove that induced apoptosis (Belka et al., 2000b; Engels et al., intact Lck is absent in JCaM1.6 cells that do not 2000; Wieder et al., 2001).
Recommended publications
  • Promoter Janus Kinase 3 Proximal Characterization and Analysis Of
    The Journal of Immunology Characterization and Analysis of the Proximal Janus Kinase 3 Promoter1 Martin Aringer,2*† Sigrun R. Hofmann,2* David M. Frucht,* Min Chen,* Michael Centola,* Akio Morinobu,* Roberta Visconti,* Daniel L. Kastner,* Josef S. Smolen,† and John J. O’Shea3* Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase essential for signaling via cytokine receptors that comprise the common ␥-chain (␥c), i.e., the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Jak3 is preferentially expressed in hemopoietic cells and is up-regulated upon cell differentiation and activation. Despite the importance of Jak3 in lymphoid development and immune function, the mechanisms that govern its expression have not been defined. To gain insight into this issue, we set out to characterize the Jak3 promoter. The 5؅-untranslated region of the Jak3 gene is interrupted by a 3515-bp intron. Upstream of this intron and the transcription initiation site, we identified an ϳ1-kb segment that exhibited lymphoid-specific promoter activity and was responsive to TCR signals. Truncation of this fragment revealed that core promoter activity resided in a 267-bp fragment that contains putative Sp-1, AP-1, Ets, Stat, and other binding sites. Mutation of the AP-1 sites significantly diminished, whereas mutation of the Ets sites abolished, the inducibility of the promoter construct. Chromatin immunoprecipitation assays showed that histone acetylation correlates with mRNA expression and that Ets-1/2 binds this region. Thus, transcription factors that bind these sites, especially Ets family members, are likely to be important regulators of Jak3 expression.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device
    micromachines Article Determination of the Membrane Transport Properties of Jurkat Cells with a Microfluidic Device Tianhang Yang 1,2, Ji Peng 2, Zhiquan Shu 2,3, Praveen K. Sekar 2, Songjing Li 1,* and Dayong Gao 2,* 1 Department of Fluid Control and Automation, Harbin Institute of Technology, Harbin 150001, Heilongjiang, China; [email protected] 2 Mechanical Engineering, University of Washington, Seattle, WA 98195, USA; [email protected] (J.P.); [email protected] (Z.S.); [email protected] (P.K.S.) 3 School of Mechanical and Materials Engineering, Washington State University, Everett, WA 98201, USA * Correspondence: [email protected] (S.L.); [email protected] (D.G.); Tel.: +86-451-86418318 (S.L.); +1-206-543-1411 (D.G.) Received: 25 October 2019; Accepted: 26 November 2019; Published: 29 November 2019 Abstract: The Jurkat cell is an immortalized line of human acute lymphocyte leukemia cells that is widely used in the study of adoptive cell therapy, a novel treatment of several advanced forms of cancer. The ability to transport water and solutes across the cell membrane under different temperatures is an important factor for deciding the specific protocol for cryopreservation of the Jurkat cell. In this study we propose a comprehensive process for determination of membrane transport properties of Jurkat cell. using a novel microfluidic controlled single cell-trapping system. The osmotic behavior of an individual Jurkat cell to water and dimethyl sulfoxide (DMSO), a commonly used cryoprotective agent (CPA), under constant temperature, was recorded under a microscope utilizing the modified microfluidic system. The images of the Jurkat cell under osmotic change were processed to obtain a relationship between cell volume change and time.
    [Show full text]
  • Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
    Published OnlineFirst June 13, 2011; DOI: 10.1158/1078-0432.CCR-10-2616 Clinical Cancer Molecular Pathways Research Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors Juan Carlos Montero1, Samuel Seoane1, Alberto Ocaña2,3, and Atanasio Pandiella1 Abstract Dasatinib is a small molecule tyrosine kinase inhibitor that targets a wide variety of tyrosine kinases implicated in the pathophysiology of several neoplasias. Among the most sensitive dasatinib targets are ABL, the SRC family kinases (SRC, LCK, HCK, FYN, YES, FGR, BLK, LYN, and FRK), and the receptor tyrosine kinases c-KIT, platelet-derived growth factor receptor (PDGFR) a and b, discoidin domain receptor 1 (DDR1), c-FMS, and ephrin receptors. Dasatinib inhibits cell duplication, migration, and invasion, and it triggers apoptosis of tumoral cells. As a consequence, dasatinib reduces tumoral mass and decreases the metastatic dissemination of tumoral cells. Dasatinib also acts on the tumoral microenvironment, which is particularly important in the bone, where dasatinib inhibits osteoclastic activity and favors osteogenesis, exerting a bone-protecting effect. Several preclinical studies have shown that dasatinib potentiates the antitumoral action of various drugs used in the oncology clinic, paving the way for the initiation of clinical trials of dasatinib in combination with standard-of-care treatments for the therapy of various neoplasias. Trials using combinations of dasatinib with ErbB/HER receptor antagonists are being explored in breast, head and neck, and colorectal cancers. In hormone receptor–positive breast cancer, trials using combina- tions of dasatinib with antihormonal therapies are ongoing. Dasatinib combinations with chemother- apeutic agents are also under development in prostate cancer (dasatinib plus docetaxel), melanoma (dasatinib plus dacarbazine), and colorectal cancer (dasatinib plus oxaliplatin plus capecitabine).
    [Show full text]
  • CD28 Costimulation in Jurkat Cells Signaling Networks Triggered By
    Quantitative Analysis of Phosphotyrosine Signaling Networks Triggered by CD3 and CD28 Costimulation in Jurkat Cells This information is current as Ji-Eun Kim and Forest M. White of September 26, 2021. J Immunol 2006; 176:2833-2843; ; doi: 10.4049/jimmunol.176.5.2833 http://www.jimmunol.org/content/176/5/2833 Downloaded from References This article cites 47 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/176/5/2833.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Quantitative Analysis of Phosphotyrosine Signaling Networks Triggered by CD3 and CD28 Costimulation in Jurkat Cells1 Ji-Eun Kim and Forest M. White2 The mechanism by which stimulation of coreceptors such as CD28 contributes to full activation of TCR signaling pathways has been intensively studied, yet quantitative measurement of costimulation effects on functional TCR signaling networks has been lacking.
    [Show full text]
  • Dipropylcyclopentylxanthine Triggers Apoptosis in Jurkat T Cells by a Receptor-Independent Mechanism
    Cell Death and Differentiation (1997) 4, 639 ± 646 1997 Stockton Press All rights reserved 13509047/97 $12.00 Dipropylcyclopentylxanthine triggers apoptosis in Jurkat T cells by a receptor-independent mechanism 1 1 1 2+ Maribel Mirabet , Josefa Mallol , Carmen Lluis and Rafael apoptosis follows an increase in [Ca ]i, requires protein Franco1,2 synthesis, and is manifested by endogenous nuclease activation which results in DNA fragmentation. At the optical 1 Departament de BioquõÂmica i Biologia Molecular, Facultat de QuõÂmica, microscopy level, apoptosis can be suspected in cells Universitat de Barcelona, Catalonia, Spain presenting a nucleus with condensed chromatin (reviewed 2 correspondence author: Rafael Franco, Departament de BioquõÂmica i Biologia in McConkey et al, 1990; Cohen, 1993). Molecular, Facultat de QuõÂmica, MartõÂ FranqueÁs 1, 08028 Barcelona, Spain. Purine compounds have been widely used in the therapy tel: 343-4021208; fax: 343-4021219; email: [email protected] of proliferative diseases. 6-mercaptopurine and 6-thiogua- Received 24.3.97; accepted 12.6.97 nine were among the first to be used (Hitchings, 1991). Edited by M.L. Gougeon These compounds are metobolized in the cell and some of the resulting products interfere with DNA synthesis. Thus, replication of DNA in cancer cells does not occur and tumor Abstract cell proliferation is blocked. Recent studies have demon- strated that several purine analogs used as anticancer drugs 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX), a xanthine are cytotoxic because they induce apoptosis in proliferating analog used as selective antagonist of adenosine receptors, cells. Thus, 2-chloro-2'-deoxyadenosine and 9-b-D-arabino- caused apoptosis in a human leukemia T cell line.
    [Show full text]
  • Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways
    University of Montana ScholarWorks at University of Montana Biological Sciences Faculty Publications Biological Sciences 1-3-2013 Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes University of Montana - Missoula, [email protected] Wan-Jui Lee Laurens van der Maaten Paul Shannon Follow this and additional works at: https://scholarworks.umt.edu/biosci_pubs Part of the Biology Commons Let us know how access to this document benefits ou.y Recommended Citation Grimes, Mark L.; Lee, Wan-Jui; van der Maaten, Laurens; and Shannon, Paul, "Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways" (2013). Biological Sciences Faculty Publications. 178. https://scholarworks.umt.edu/biosci_pubs/178 This Article is brought to you for free and open access by the Biological Sciences at ScholarWorks at University of Montana. It has been accepted for inclusion in Biological Sciences Faculty Publications by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. Wrangling Phosphoproteomic Data to Elucidate Cancer Signaling Pathways Mark L. Grimes1*, Wan-Jui Lee2, Laurens van der Maaten2, Paul Shannon3 1 Division of Biological Sciences, University of Montana, Missoula, Montana, United States of America, 2 Pattern Recognition and Bioinformatics Group, Delft University of Technology, CD Delft, The Netherlands, 3 Fred Hutchison Cancer Research Institute, Seattle, Washington, United States of America Abstract The interpretation of biological data sets is essential for generating hypotheses that guide research, yet modern methods of global analysis challenge our ability to discern meaningful patterns and then convey results in a way that can be easily appreciated. Proteomic data is especially challenging because mass spectrometry detectors often miss peptides in complex samples, resulting in sparsely populated data sets.
    [Show full text]
  • Mining Microarray Data to Identify Transcription Factors Expressed in Naıve Resting but Not Activated T Lymphocytes
    Genes and Immunity (2004) 5, 16–25 & 2004 Nature Publishing Group All rights reserved 1466-4879/04 $25.00 www.nature.com/gene Mining microarray data to identify transcription factors expressed in naı¨ve resting but not activated T lymphocytes C Argyropoulos1,2, GC Nikiforidis2, M Theodoropoulou1, P Adamopoulos1, S Boubali3, TN Georgakopoulos4, F Paliogianni3, AG Papavassiliou4 and A Mouzaki1 1Laboratory of Hematology & Transfusion Medicine, University of Patras, Patras, Greece; 2Laboratory of Medical Physics, University of Patras, Patras, Greece; 3Laboratory of Microbiology, University of Patras, Patras, Greece; 4Laboratory of Biological Chemistry, Medical School, University of Patras, Patras, Greece Transcriptional repressors controlling the expression of cytokine genes have been implicated in a variety of physiological and pathological phenomena. An unknown repressor that binds to the distal NFAT element of the interleukin-2 (IL-2) gene promoter in naive T-helper lymphocytes has been implicated in autoimmune phenomena and has emerged as a potentially important factor controlling the latency of HIV-1. The aim of this paper was the identification of this repressor. We resorted to public microarray databases looking for DNA-binding proteins that are present in naı¨ve resting T cells but are downregulated when the cells are activated. A Bayesian data mining statistical analysis uncovered 25 candidate factors. Of the 25, NFAT4 and the oncogene ets-2 bind to the common motif AAGGAG found in the HIV-1 LTR and IL-2 probes. Ets-2 binding site contains the three G’s that have been shown to be important for binding of the unknown factor; hence, we considered it the likeliest candidate.
    [Show full text]
  • Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
    cancers Review Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia Kalpana K. Bhanumathy 1,*, Amrutha Balagopal 1, Frederick S. Vizeacoumar 2 , Franco J. Vizeacoumar 1,3, Andrew Freywald 2 and Vincenzo Giambra 4,* 1 Division of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (A.B.); [email protected] (F.J.V.) 2 Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; [email protected] (F.S.V.); [email protected] (A.F.) 3 Cancer Research Department, Saskatchewan Cancer Agency, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada 4 Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, FG, Italy * Correspondence: [email protected] (K.K.B.); [email protected] (V.G.); Tel.: +1-(306)-716-7456 (K.K.B.); +39-0882-416574 (V.G.) Simple Summary: Protein phosphorylation is a key regulatory mechanism that controls a wide variety of cellular responses. This process is catalysed by the members of the protein kinase su- perfamily that are classified into two main families based on their ability to phosphorylate either tyrosine or serine and threonine residues in their substrates. Massive research efforts have been invested in dissecting the functions of tyrosine kinases, revealing their importance in the initiation and progression of human malignancies. Based on these investigations, numerous tyrosine kinase inhibitors have been included in clinical protocols and proved to be effective in targeted therapies for various haematological malignancies.
    [Show full text]
  • The Fate of the Nuclear Matrix-Associated-Region-Binding Protein SATB1 During Apoptosis
    Cell Death and Differentiation (2000) 7, 425 ± 438 ã 2000 Macmillan Publishers Ltd All rights reserved 1350-9047/00 $15.00 www.nature.com/cdd The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis J Gotzmann*,1, M Meissner1 and C Gerner1 of human diseases arise from abnormalities in apoptosis execution, resulting either in excessive removal of cells (e.g. 1 Institute of Tumor Biology ± Cancer Research, University of Vienna, A-1090 neurodegenerative diseases)5 or in inadequate accumulation Vienna, Austria of cells (e.g. cancer).6±8 Apoptosis functionally antagonizes * Corresponding author: J Gotzmann, Institute of Tumor Biology ± Cancer mitosis, as exemplified by a disturbance of a normal balance Research, University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria. between proliferation and cell death during neoplastic Tel: +43-1-4277-65234; Fax: +43-1-4277-9651; 9 E-mail: [email protected] progression, a crucial step in malignant conversion. Even in most advanced malignancies the cell death machinery Received 2.9.99; revised 22.12.99; accepted 28.12.99 remains intact, but cells lack or repress regulatory mechan- Edited by SJ Martin isms to activate the death program sufficiently to balance enhanced cell production.10 Necrosis, a different form of cell death, is caused by Abstract severe damage of cellular homeostasis.5,11 Necrotic cells Special AT-rich sequence-binding protein 1 (SATB1), pre- swell and lose the protective function of the plasma dominantly expressed in thymocytes, was identified as a membrane, concomitant with anucleolytic pyknosis. Contra- rily, apoptotic cells shrink, leaving the plasma membrane component of the nuclear matrix protein fraction.
    [Show full text]
  • The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights Into Cell Differentiation and Function
    International Journal of Molecular Sciences Article The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function Yashwanth Subbannayya 1 , Markus Haug 1, Sneha M. Pinto 1, Varshasnata Mohanty 2, Hany Zakaria Meås 1, Trude Helen Flo 1, T.S. Keshava Prasad 2 and Richard K. Kandasamy 1,* 1 Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, 7491 Trondheim, Norway; [email protected] (Y.S.); [email protected] (M.H.); [email protected] (S.M.P.); [email protected] (H.Z.M.); trude.fl[email protected] (T.H.F.) 2 Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore 575018, India; [email protected] (V.M.); [email protected] (T.S.K.P.) * Correspondence: [email protected] Abstract: CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. The activation and functional status of CD4+ T cells is important for adequate responses to pathogen infections but has also been associated with auto-immune disorders and survival in several cancers. In the current study, we carried out a label-free high-resolution FTMS-based proteomic profiling of resting and T cell receptor-activated (72 h) primary human CD4+ T cells from peripheral blood of healthy donors as well as SUP-T1 cells. We identified 5237 proteins, of which significant alterations in the levels of 1119 proteins were observed between resting and activated CD4+ T cells.
    [Show full text]
  • CD8 Co-Receptor Enhances T-Cell Activation Without Any Effect on Initial Attachment
    cells Article CD8 Co-Receptor Enhances T-Cell Activation without Any Effect on Initial Attachment Philippe Robert 1,2,*, Laurent Limozin 1,*, P. Anton van der Merwe 3,* and Pierre Bongrand 1,* 1 Laboratoire Adhesion et Inflammation, UMR INSERM 1067, UMR CNRS 7333, Aix-Marseille Université, Case 937, CEDEX 09, 13288 Marseille, France 2 Assistance Publique–Hôpitaux de Marseille, Lab. Immunologie, Hôpital de la Concception, 13005 Marseille, France 3 Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK * Correspondence: [email protected] (P.R.); [email protected] (L.L.); [email protected] (P.A.v.d.M.); [email protected] (P.B.) Abstract: The scanning of surrounding tissues by T lymphocytes to detect cognate antigens requires high speed, sensitivity and specificity. T-cell receptor (TCR) co-receptors such as CD8 increase detection performance, but the exact mechanism remains incompletely understood. Here, we used a laminar flow chamber to measure at the single molecule level the kinetics of bond formation and rupture between TCR- transfected CD8+ and CD8− Jurkat cells and surfaces coated with five peptide- exposing major histocompatibility antigens (pMHCs) of varying activating power. We also used interference reflection microscopy to image the spreading of these cells dropped on pMHC-exposing surfaces. CD8 did not influence the TCR–pMHC interaction during the first few seconds following cell surface encounter, but it promoted the subsequent spreading responses, suggesting that CD8 was involved in early activation rather than binding. Further, the rate and extent of spreading, but not the lag between contact and spreading initiation, depended on the pMHC.
    [Show full text]